Beijing
Dalian
Bohai Rim
Yantai
Seoul
Qingdao
Tokyo
Osaka
Shanghai
Yangtze River
Delta Rim
Shenzhen
Pearl River
Delta Rim
Figure 1. The 31 province 2010 GDP and growth in China
Shandong is the forefront in the field of biomedicine and marine life in
China .
Shandong is the largest province in pharmaceutical industry, and the sales income is No. 1 .
(data from : National Development and Reform Commission)
?
?
“ UN Habitat Scroll of Honor Award”
“Chinese Top Habitat Award ”
“Chinese City with the Best Investment
Environment”
“Top Chinese Tourist City”
“National Model City in Environmental
Protection”
“Chinese City with Top Innovation
Environment”
“Chinese City with Top Innovation Power”
“ Chinese City with Top Innovation
Achievements”
Yantai is rich in biological resources, and in the biological industry, there has formed a certain scale and characteristics with a number of innovative companies with core competitiveness.
Shandong Province 2011 GDP ranking:
Qingdao: 104 billion USD
Yantai: 77 billion USD
Jinan: 69 billion USD
(data from : Shandong Development and Reform Commission)
Total Area : 1.37 hectares
The general population :
6,470,000
Yantai High-Tech Zone:
Total Area:48.8 square km .
Biotechnology Park:
3 kilometers far away from
Yantai Government.
• Yantai University
• Binzhou Medical College
• Ocean University of China
• China Agricultural University (Yantai)
• Ludong University
• Shandong Institute of Business and
Technology
• Yantai Institute of Coastal Zone Research,
Chinese Academy of Sciences
• Naval Aeronautical Engineering Institute
Subway
BIOasis
6 km away from Yantai Laishan
International Airport;
15 km away from Yantai Port;
200 km away from Qingdao Port;
89 sea miles away from Dalian Port
Inter-city express railway
1046 acres, total area of the park;
566 acres, research and development area;
480 acres, supporting area;
560,000 square meters designed R & D area ;
510,000 square meters supporting area .
Enterprise-style management with strong governmental support
The planning, policy making and daily management of the park is a collaborative effort among Shandong provincial government, Yantai municipal government ,
Yantai High-Tech Zone and Shandong Luye Pharma Group Ltd..
This ensures efficient progression of the park's construction and subsequent development.
Shandong International Biotechnology Park Development Co., Ltd.,oversee the design, construction, development, management, financing services, business consultation, logistics, etc. of the park..
:
Bio-pharma: gene therapy, antibody drug, targeted therapeutics, stem cell therapy, translational medicine, personalized therapy, modern traditional Chinese medicine, diagnostic reagents, medical devices, etc..
Marine Biology: marine pharmaceuticals, oceanic functional food and cosmetics, novel marine biomaterial, marine bio-enzyme, etc..
Biological Agriculture: transgenic breeding, animal vaccine, bio-pesticide, biofeeds, plant growth regulator, etc..
Health care: The international medical rehabilitation center, Cosmetic Medicine,
Care training center, etc..
Services
Policies
Consultation
Platforms
Training
Funding
Progress
-functional zone
Progress
- 20 Enterprise enterred
Progress
- Enterred institute
Progress
• Currently the starting building has been completed and put into use, and the 2 nd phase, total area of 120,000 square meters R&D Incubator, has been fully built.
• Has attracted more than 20 projects, more than half of which were founded by the outstanding returnees talent, introduced
15 high-level personnel with doctoral degrees, 12 of them having overseas study background.
Core technology
• Platform of long-term sustained release microsphere
Relying on the ”State Key Laboratory of long-term and targeted agents”, the research is in the international and domestic leading position. 8 projects with independent intellectual property rights, 3 research enter the clinical phase, in which two has entered in U.S.
FDA declaration.
• Development platform of holistic monoclonal antibody drug
Relying on the biotechnology center in the park, (co-found with Singapore A-bio biotechnology company), committed to the human monoclonal antibody drug development.
• R&D platform of Marine active material
Base on the marine biotechnology center (co-build with
Chinese Academy of Sciences Institute of
Oceanology, Institute of coastal zone research), committed to the development of marine pharmaceuticals and other high value products.
Progress
Shandong international biotech park has been included into the comprehensive national drug research and development technology platform, an important part of ”Shandong Key New Drug
Creation Center ", a national innovative drugs (Yantai) incubation base.
The foundation stone laying ceremony of Shandong International Biotechnology Park was held on August 6, 2010. There were more than 700 attendees, as well as more than
10 National Academy Members and industry leaders.
Big Event -
Leading Care
Jia Qinglin, Chairman of the CPPCC National Committee, visit Shandong
International Biotechnology Park to guide the work during his investigation in Shandong
Big Event -
Leading Care
November 6, 2011, Sang Guowei, vice chairman of the NPC Standing
Committee, director of Chinese Pharmaceutical Association, and his entourage had a visit to Shandong international biotech park.
Big Event -
Leading Care
After 10 years, to the year of 2020 :
Settled more than 100 R&D centers from the famous enterprises; settled more than 100 R&D centers / laboratories from domestic and foreign wellknown research institutes; settled more than 300 biotechnology companies.
Have more than 10 internationally renowned brand products, more than
100 listed products with independent intellectual property and 200 of the leading international scientific and technological achievements, the international and domestic patent applications will reach 5000;
Attract 10 renowned scientists in the field of international biotechnology; 20 domestic famous scientist in the field of biotechnology; 200 academic leaders;
Over one million permanent staff will locate in the park